22 May 2013

The latest supply chain news, views and features for the healthcare sector

News

UPS buys Hungarian pharma firm
UPS has announced it will acquire Hungary-based pharmaceutical logistics company Cemelog in order to strengthen its healthcare business in Europe, as part of a global growth and investment strategy ...

Awards to recognise achievement in Health & Pharmaceuticals
Healthcare and the pharmaceuticals industry play a critical role in people’s lives and the organisations supplying their products are increasingly looking for innovative and modern solutions to get the best out of their supply chains, enabling them to...

New European supply chain projects director for Omega Pharma
Sue Austin has been appointed as global healthcare company Omega Pharma’s European supply chain projects director...

More News

Viewpoint

Tricky operations
Getting closer to the customer is the goal of most organisations and this is particularly true for manufacturers of implantable medical devices. Although there is considerable product innovation to provide better clinical results, the supply...

Efficiency is on the cards
The drive for efficiency in physical supply chains has benefited firms prepared to adopt new models and technology. Meanwhile, the financial supply chain has ground to make up if it is to avoid becoming a significant bottleneck. ...

More Viewpoint

Features

The English patient
Healthcare is a highly political subject. When the UK’s NHS outsourced its supply chain to a logistics services company close scrutiny ensued. But the stakes are high – assurances were given that savings of €127million would bemade each year for ten...

What's to be heard at ESC 2008
The sixth in the series, the Extended Supply Chain 2008 conference looks set to surpass all others to date. ...

More Features

Corporate Insight

Balancing risk
Two major humanitarian disasters - the Burmese cyclone and the Chinese earthquake - provided a sombre backdrop to ''Supply Chain Standard''s Roundtable discussion on supply chain risk. But as Dave Food, business development director from the meeting's ...

Taking the trial out of pharmaceutical testing
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and - given time limitations on patents - the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most...

More Corporate Insight
Executive Jobs
Job Title Job Location Job Position
3PL Manager ... Warwickshire Permanent
Account Director ... Warwickshire Permanent
Account Director - Technology ... Warwickshire Permanent
Assistant Procurement Director ... London Permanent
Business Development Manager ... Yorkshire Permanent
Capex Category Manager ... Warwickshire Permanent
More Jobs

User Account Logon Form

Quick Search Form

Advanced Search

Adverts